Haploidentical Stem Cell Transplant With Prophylactic With Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL
Conditions: Multiple Myeloma; CLL; Chronic Lymphocytic Leukemia; Lymphoma Interventions: Radiation: Total Body Irradiation; Procedure: Haploidentical Stem Cell Transplantation; Biological: CD56-Enriched Donor Lymphocyte Infusion; Drug: Bendamustine; Drug: Fludarabine; Drug: Rituximab Sponsors: Noah Merin; Miltenyi Biotec GmbH; TEVA Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Leukemia | Lymphoma | Myeloma | Rituxan | Stem Cell Therapy | Stem Cells | Transplants | Treanda